GenEdit
is a California-based biotechnology company that develops and commercializes curative therapies for the treatment of genetic diseases... Read moreGenEdit
is a California-based biotechnology company that develops and commercializes curative therapies for the treatment of genetic diseases... Read more
News
Jan 25, 2024
PMLiVE
GenEdit: Roche's Genentech and GenEdit enter autoimmune disease partnership worth up to $644m
Jan 23, 2024
Endpoints News
GenEdit: Gene editing delivery biotech GenEdit partners with Genentech, raises another $24M
Feb 28, 2023
Korea Biomedical Review
GenEdit: KIMCo jointly invests $1.7 mil. in US biotech firm GenEdit
Feb 02, 2022
Pharamceutical Technology
GenEdit: Sarepta and GenEdit partner to develop neuromuscular disease therapies
Feb 01, 2022
Benzinga
GenEdit: Sarepta Bets On GenEdit's Nanoparticles' In $57M Gene Editing Partnership
Sep 27, 2021
Citybizlist
GenEdit: GenEdit Raises $26M Series A
Sep 23, 2021
MedCity News
GenEdit: Aiming for better genetic medicines delivery, startup GenEdit grabs $26M
Sep 23, 2021
BioSpace
GenEdit: GenEdit Uncloaks to Solve Gene Editing "Delivery Problem"
Sep 23, 2021
BioSpace
GenEdit: GenEdit Announces Series A Financing and Provides Research Update at TIDES 2021
Sep 22, 2021
Business Wire
Press Release: GenEdit : GenEdit Expands Leadership Team to Advance Targeted Genetic Medicines into Clinical Trials
GenEdit Competitors
1
2
3
4
5
6
7
8
9
10